AI watchdog for cancer radiation: could it prevent costly mistakes?

NCT ID NCT07463833

Recruiting now Knowledge-focused Sponsor: UNC Lineberger Comprehensive Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests an artificial intelligence (AI) tool designed to help doctors and physicists review radiation treatment plans for cancer patients before therapy begins. The AI highlights differences in how providers plan treatments and flags potential warning signs, aiming to reduce errors and improve safety. About 207 participants (providers and prostate cancer patients) will take part, with the AI embedded in routine peer-review meetings.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Artificial intelligence (AI) decision-support software
What this could lead to: If successful, this AI tool could help doctors and physicists catch more mistakes in radiation treatment plans, making cancer therapy safer for patients.
What could go wrong: This is an early-stage study focused on process improvement, not a direct treatment. The AI may not reduce errors significantly or could add complexity without clear benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer neoplasm prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER PROSTATE CANCER

Contacts and locations

Locations

University of North Carolina at Chapel Hill, Department of Radiation Oncology
RECRUITING

Chapel Hill, North Carolina, 27599, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.